Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
We're Not Very Worried About Grace Therapeutics' (NASDAQ:GRCE) Cash Burn Rate [Yahoo! Finance]
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference